These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26233771)

  • 21. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
    Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
    Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction.
    Balta S; Celik T; Ozturk C; Kaya MG; Aparci M; Yildirim AO; Demir M; Kilic S; Aydin İ; Iyisoy A
    Am J Emerg Med; 2016 Aug; 34(8):1542-7. PubMed ID: 27238848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial Infarction.
    Gong X; Lei X; Huang Z; Song Y; Wang Q; Qian J; Ge J
    J Cardiovasc Transl Res; 2021 Aug; 14(4):728-734. PubMed ID: 32212039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.
    Su Q; Ye Z; Sun Y; Yang H; Li L
    Scand J Clin Lab Invest; 2018 Jul; 78(4):318-324. PubMed ID: 29703083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention.
    Zhang Q; Hu M; Ma S
    J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
    Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Celik IE; Kilic A
    Angiology; 2015 Aug; 66(7):644-51. PubMed ID: 25124682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Cheng C; Liu XB; Bi SJ; Lu QH; Zhang J
    PLoS One; 2019; 14(8):e0220654. PubMed ID: 31369621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation of admission neutrophil/lymphocyte ratio to angiographic no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary coronary intervention].
    Niu X; Zhang Y; He S; Chen D; Yan D; Yao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):856-60. PubMed ID: 25294082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of endothelial dysfunction and no-reflow during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Levi Y; Sultan A; Alemayehu M; Wall S; Lavi S
    Cardiovasc Revasc Med; 2016 Dec; 17(8):552-555. PubMed ID: 27638105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of the HALP score for no-reflow phenomenon and short-term mortality in patients with ST-elevation myocardial infarction.
    Toprak K; Toprak İH; Acar O; Ermiş MF
    Postgrad Med; 2024 Mar; 136(2):169-179. PubMed ID: 38356155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.
    Yuksel M; Isik T; Tanboga IH; Ayhan E; Erimsah ME; Topcu S; Demirelli S; Aksakal E; Sevimli S
    Clin Appl Thromb Hemost; 2017 May; 23(4):329-335. PubMed ID: 27418637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.